Medtronic
MDT
85.51
-1.58
-1.81%
Medtronic
US · MDT
#176 by market cap
Listed 1970
85.51
-1.58
-1.81%
Live - 5344 symbols - heartbeat 3s ago
· 2026-10-08 08:29
Pre-market
85.51
0.00%
After-hours
85.61
+0.11%
Overnight
85.50
-0.01%
- Market cap
- 109.38B
- P/E (TTM)i
- 21.06
- P/Bi
- 2.18
- EPSi
- 3.73
- Div yieldi
- 3.33%
- 52W posi
- 44%
Reader sentiment
Are you bullish or bearish on MDT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 15 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 87.57% -0.04pp
- Institutions
- 2,558 -15
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund71.16%
Public Company5.71%
Private Company3.41%
Hedge Fund2.84%
Government Pension Fund1.96%
Sovereign Wealth Fund1.39%
Insurance Company0.44%
Family Office/Trust0.31%
Government0.15%
Other12.63%
Top holders as of 2026-06-30
BlackRock
8.91% · 114.02M sh
Vanguard Capital Management, LLC
7.12% · 91.02M sh
State Street Global Advisors
4.96% · 63.40M sh
Vanguard Portfolio Management, LLC
2.66% · 34.06M sh
Geode Capital Management, LLC
2.36% · 30.19M sh
Other
73.99%
Capital Research
1.69% · 21.65M sh
J.P. Morgan Asset Management, Inc.
1.51% · 19.26M sh
Deutsche Asset & Wealth Management
1.42% · 18.20M sh
Franklin Resources
1.36% · 17.41M sh
MFS Investment Management
1.36% · 17.39M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 28 buys · 17 sells
| Name | Role | Stake |
|---|---|---|
| Geoffrey Martha | Chairperson & CEO | 0.02% |
| Randall Hogan | Independent Director | 0.00% |
| Brett Wall | Executive VP & President of Neuroscience Portfolio | 0.00% |
| Craig Arnold | Lead Independent Director | 0.00% |
| Gregory Smith | Executive Vice President of Global Operations & Supply Chain | 0.00% |
| Michael Marinaro | Executive VP & President of Surgical Operating Unit | 0.00% |
| Sean Salmon | Executive VP & President of Cardiovascular Portfolio | 0.00% |
| Matthew Walter | Chief Human Resources Officer | 0.00% |
| Kendall Powell | Independent Director | 0.00% |
| Ivan Fong | General Counsel | 0.00% |
| Scott Donnelly | Independent Director | 0.00% |
| Elizabeth Nabel | Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-15 | Harry Kiil | President of Cranial & Spinal Technologies Operating Unit | Open Market Disposition | -1,483 | $93.65 |
| 2026-09-14 | Denise Blomquist | Global Controller & Principal Accounting Officer | Other Disposition | -600 | -- |
| 2026-08-19 | Michael Marinaro | Executive VP & President of Surgical Operating Unit | Sale to Issuer | -1,084 | $92.30 |
| 2026-08-02 | Geoffrey Martha | Chairperson & CEO | Other Acquisition | +41,533 | -- |
| 2026-08-02 | Geoffrey Martha | Chairperson & CEO | Other Derivative Acquisition | +103,831 | -- |
| 2026-08-02 | Geoffrey Martha | Chairperson & CEO | Other Derivative Acquisition | +568,152 | $86.68 |
| 2026-08-02 | Thierry Pieton | Chief Financial Officer | Other Acquisition | +11,537 | -- |
| 2026-08-02 | Thierry Pieton | Chief Financial Officer | Other Derivative Acquisition | +28,842 | -- |
| 2026-08-02 | Thierry Pieton | Chief Financial Officer | Other Derivative Acquisition | +81,945 | $86.68 |
| 2026-08-02 | Harry Kiil | President of Cranial & Spinal Technologies Operating Unit | Other Acquisition | +9,230 | -- |
| 2026-08-02 | Harry Kiil | President of Cranial & Spinal Technologies Operating Unit | Other Derivative Acquisition | +23,074 | -- |
| 2026-08-02 | Harry Kiil | President of Cranial & Spinal Technologies Operating Unit | Other Derivative Acquisition | +65,556 | $86.68 |
| 2026-08-02 | Michael Marinaro | Executive VP & President of Surgical Operating Unit | Other Acquisition | +57,107 | -- |
| 2026-08-02 | Michael Marinaro | Executive VP & President of Surgical Operating Unit | Other Derivative Acquisition | +27,400 | -- |
| 2026-08-02 | Michael Marinaro | Executive VP & President of Surgical Operating Unit | Other Derivative Acquisition | +77,848 | $86.68 |
| 2026-08-02 | Michelle Quinn | EVP, General Counsel & Secretary | Other Acquisition | +6,346 | -- |
| 2026-08-02 | Michelle Quinn | EVP, General Counsel & Secretary | Other Derivative Acquisition | +15,863 | -- |
| 2026-08-02 | Michelle Quinn | EVP, General Counsel & Secretary | Other Derivative Acquisition | +45,070 | $86.68 |
| 2026-08-02 | Kweli Thompson | Operating Unit President of Cardiac Rhythm Management | Other Acquisition | +6,923 | -- |
| 2026-08-02 | Kweli Thompson | Operating Unit President of Cardiac Rhythm Management | Other Derivative Acquisition | +17,306 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:29:32 · For reference only, not investment advice and not tailored to your situation.